Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The encoded gene product presumably interacts with YY1 protein\; however, its exact function is not known. Additionally we are shipping YY1AP1 Proteins (2) and many more products for this protein.
Showing 10 out of 11 products:
Human Polyclonal YY1AP1 Primary Antibody for ICC, IF - ABIN4366547
Zhao, Parpart, Takai, Roessler, Budhu, Yu, Blank, Zhang, Jia, Ye, Qin, Tang, Thorgeirsson, Wang: Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma. in Oncogene 2015
A YAP (show YAP1 Antibodies)/TAZ (show TAZ Antibodies)-miR (show MLXIP Antibodies)-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions
activates YAP (show YAP1 Antibodies) and stimulates cancer cell growth. Knockdown of ERBB3 (show ERBB3 Antibodies) or HBEGF (show HBEGF Antibodies) eliminates YAP (show YAP1 Antibodies) effects on cell growth and transformation
YY1AP1 may serve as a key molecular target for EpCAM (show EPCAM Antibodies)(+) AFP (show AFP Antibodies)(+) HCC (show FAM126A Antibodies) subtype
we report that YAP (show YAP1 Antibodies) and its downstream transcriptional targets CCN1 (show CCNA2 Antibodies) and CCN2 (show CTGF Antibodies) are markedly elevated in keratinocytes in human skin basal cell carcinoma
knowledge of how YAP (show YAP1 Antibodies) and TAZ (show TAZ Antibodies) function as mechanosensors and mechanotransducers
F-Actin, assembled in response to Galpha12 (show GNA12 Antibodies)/13 induced RhoA (show RHOA Antibodies)-GTP (show AK3 Antibodies), promotes dephosphorylation and activation of the YAP (show YAP1 Antibodies) oncogene (show RAB1A Antibodies).
Study reports that physical and architectural features of a multicellular sheet inform cells about their proliferative capacity through mechanical regulation of YAP (show YAP1 Antibodies) and TAZ (show TAZ Antibodies), known mediators of Hippo signaling and organ growth. YAP (show YAP1 Antibodies)/TAZ (show TAZ Antibodies) activity is confined to cells exposed to mechanical stresses.
The expression of YAP (show YAP1 Antibodies)/TAZ (show TAZ Antibodies) and ECM (show MMRN1 Antibodies)-related-genes is impacted on physiologically relevant substrates. YAP (show YAP1 Antibodies) was upregulated in cells on softer substrates.
Studies indicate that the transcriptional co-activators YAP (show YAP1 Antibodies) and TAZ (show TAZ Antibodies) recently emerged as key mediators of the biological effects that are observed in response to extracellular matrix (ECM (show MMRN1 Antibodies)) elasticity and cell shape.
Data suggest that defective expression of LATS2 (show LATS2 Antibodies) is attributable to FOXP3 (show FOXP3 Antibodies) defects and may be a major independent determinant of YAP (show YAP1 Antibodies) protein elevation in cancer.
The encoded gene product presumably interacts with YY1 protein\; however, its exact function is not known. Alternative splicing results in multiple transcript variants encoding different isoforms.
YY1-associated protein 1
, YY1 associated protein 1
, Dingo protein
, hepatocellular carcinoma susceptibility protein
, hepatocellular carcinoma-associated protein 2